Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Laryngoscope. 2011 Nov 22;122(1):174–189. doi: 10.1002/lary.22392

Figure 7. AR42 was well tolerated with no clinically significant abnormalities in organ tissue histology identified during 6-month of oral dosing.

Figure 7

The FVB/N mice described in Figure 6 were analyzed for histopathology across multiple organs. Shown are representative sections from the cerebral cortex, cardiac muscle, skeletal muscle, kidney, and liver. Mice fed AR42 chow for 3-months showed no detectable differences relative to control mice. Mice treated with AR42 for 6-months displayed centrilobular hepatocellular hypertrophy, a common adaptive response to xenobiotics.